- Home
- LOB vs ARWR Comparison
LOB vs ARWR Comparison
Compare LOB & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOB
- ARWR
- Stock Information
- Founded
- LOB 2008
- ARWR 2003
- Country
- LOB United States
- ARWR United States
- Employees
- LOB N/A
- ARWR N/A
- Industry
- LOB Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- LOB Finance
- ARWR Health Care
- Exchange
- LOB Nasdaq
- ARWR Nasdaq
- Market Cap
- LOB 2.2B
- ARWR 2.5B
- IPO Year
- LOB 2015
- ARWR 1993
- Fundamental
- Price
- LOB $47.67
- ARWR $19.02
- Analyst Decision
- LOB Buy
- ARWR Buy
- Analyst Count
- LOB 6
- ARWR 11
- Target Price
- LOB $45.67
- ARWR $45.33
- AVG Volume (30 Days)
- LOB 249.2K
- ARWR 997.3K
- Earning Date
- LOB 10-23-2024
- ARWR 11-26-2024
- Dividend Yield
- LOB 0.25%
- ARWR N/A
- EPS Growth
- LOB 39.66
- ARWR N/A
- EPS
- LOB 1.84
- ARWR N/A
- Revenue
- LOB $405,743,000.00
- ARWR $19,648,000.00
- Revenue This Year
- LOB N/A
- ARWR N/A
- Revenue Next Year
- LOB $16.54
- ARWR $100.95
- P/E Ratio
- LOB $25.93
- ARWR N/A
- Revenue Growth
- LOB 9.13
- ARWR N/A
- 52 Week Low
- LOB $31.03
- ARWR $17.05
- 52 Week High
- LOB $50.57
- ARWR $39.83
- Technical
- Relative Strength Index (RSI)
- LOB 55.41
- ARWR 39.78
- Support Level
- LOB $47.67
- ARWR $21.20
- Resistance Level
- LOB $49.19
- ARWR $22.03
- Average True Range (ATR)
- LOB 1.56
- ARWR 0.89
- MACD
- LOB 0.54
- ARWR -0.15
- Stochastic Oscillator
- LOB 75.31
- ARWR 19.40
About LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.